2000
DOI: 10.1006/geno.2000.6172
|View full text |Cite
|
Sign up to set email alerts
|

NABC1 (BCAS1): Alternative Splicing and Downregulation in Colorectal Tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
7
0

Year Published

2002
2002
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(9 citation statements)
references
References 4 publications
2
7
0
Order By: Relevance
“…Proteins related to other cancers are also found in this dataset, such as BCAS1, which has been described as a strong candidate oncogene for breast cancer (Collins et al, 1998). Surprisingly, compared to breast cancer, in which upregulation is observed for this protein, an opposite trend is found in colorectal cancer (Correa et al, 2000). The same trend is found in our study; once again, proteomics data of organoids is recapitulating observations made with biopsy specimens.…”
Section: Establishing a Human Crc Organoid Expression Profile By Quansupporting
confidence: 88%
“…Proteins related to other cancers are also found in this dataset, such as BCAS1, which has been described as a strong candidate oncogene for breast cancer (Collins et al, 1998). Surprisingly, compared to breast cancer, in which upregulation is observed for this protein, an opposite trend is found in colorectal cancer (Correa et al, 2000). The same trend is found in our study; once again, proteomics data of organoids is recapitulating observations made with biopsy specimens.…”
Section: Establishing a Human Crc Organoid Expression Profile By Quansupporting
confidence: 88%
“…If GATA3 does help to control expression of NHERF1 this might be one mechanism consistent with its role in the less-aggressive differentiated luminal A breast cancers. Another example is BCAS1 (NABC1) which is overexpressed in breast carcinomas but downregulated in colorectal tumours [ 22 , 23 ]. Indeed, overexpression of NABC1 did not result in changes in cell-cycle or anchorage-dependent growth properties in NIH3T3 cells, implying it may not be intrinsically oncogenic [ 24 ].…”
Section: Resultsmentioning
confidence: 99%
“…The BCAS1 (Breast carcinoma amplified sequence 1, also named NABC1) gene, which was located at 20q13, was amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. [23][24][25] Correa et al 24 found that BCAS1 was overexpressed in breast tumors and both NABC1 and NABC1_5B were down-regulated in colorectal tumors. In current study, rs3787547-Aallele was identified to increase the susceptibility of OS.…”
Section: Discussionmentioning
confidence: 99%